ISIS PHARMACEUTICALS INC
CARLSBAD, CA · CIK 0000874015 · Biotech · Public
Small molecule and antisense oligonucleotide therapeutics for rare and serious diseases
ionis.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $201M
- 1 Form D · Aug 2012
- 169 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 29 granted · 11 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20122013
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $201,250,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2376 | BIOINVENU CORPORATION | — | — |
| 2377 | DNP THERAPEUTICS INC | — | $470K |
| 2378 | XFIBRA, INC. | — | — |
| 2379 | ISIS PHARMACEUTICALS INC | — | $201M |
| 2380 | MANUS BIO INC | — | $109M |
| 2381 | Jaguar Health, Inc. | — | $146M |
| 2382 | MediWound Ltd. | — | $31M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- C BENNETTExecutive Officer
- SPENCER BERTHELSENDirector
- STANLEY CROOKEDirector · Executive Officer
- RICHARD GEARYExecutive Officer
- JOSEPH KLEIN IIIDirector
- BRETT MONIAExecutive Officer
- FREDERICK MUTODirector
- B PARSHALLDirector · Executive Officer
- JOHN REEDDirector
- JOSEPH WENDERDirector
Patents
- Modulation Of Signal Transducer And Activator Of Transcription 3 (STAT3) Expressiongranted
- Methods For Modulating Tau Expression For Reducing Seizure And Modifying A Neurodegenerative Syndromegranted
- Compositions For Modulating Tau Expressiongranted
- Methods For Treating Hypercholesterolemiagranted
- Compositions And Methods For Modulating Angiopoietin-like 3 Expressiongranted
- Modulation Of Signal Transducer And Activator Of Transcription 3 (STAT3) Expressiongranted
- Methods Of Predicting Toxicitygranted
- Double Strand Compositions Comprising Differentially Modified Strands For Use In Gene Modulationapplication
- Tricyclic Nucleic Acid Analogsgranted
- Selective Reduction Of Allelic Variantsapplication
- Compositions And Methods For Modulating Apolipoprotein (a) Expressiongranted
- Conjugated Antisense Compounds And Their Usegranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.